# Beta-sitosterol for Subarachnoid Hemorrhage: Mechanistic Analysis of Recovery and Therapy

> **NCT07457333** · PHASE1,PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 40 (estimated)

## Conditions studied

- Subarachnoid Haemorrhagic Stroke

## Interventions

- **DRUG:** Supplementation of β -sitosterol
- **OTHER:** Standard medical treatment

## Key facts

- **NCT ID:** NCT07457333
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-02-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07457333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07457333, "Beta-sitosterol for Subarachnoid Hemorrhage: Mechanistic Analysis of Recovery and Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07457333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*